Figure 2.

Rates of progression to death, World Health Organization stage 4 disease, or at least 1 CD4⁺ count of <200 cells/mm³ for all women from delivery (A), all women from cessation of ARV prophylaxis (B), women with CD4⁺ count of <350 cells/mm³ at enrollment (from cessation of prophylaxis) (C), and women with CD4⁺ count of >350 cells/mm³ at enrollment (from cessation of prophylaxis (D). Abbreviations: AZT/sdNVP, zidovudine until delivery with single-dose nevirapine without postpartum prophylaxis; Triple ARV, zidovudine, lamivudine, and lopinavir/ritonavir during pregnancy and breastfeeding.